Stockreport

Arrowhead Pharmaceuticals seeks approval for obesity treatment trial in New Zealand [Yahoo! Finance]

Arrowhead Pharmaceuticals, Inc.  (ARWR) 
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arrowheadpharma.com/investor-relations
PDF Phase I/IIa clinical trial of ARO-INHBE, an investigational RNA interference (RNAi) therapy for treating obesity, in New Zealand. The company's application was submitt [Read more]